Rhonda Patrick· PhD
20 mg of melatonin per day in addition to radiation increased glioblastoma 1-year survival rate from 1% to 43%.
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
20 mg of melatonin per day in addition to radiation increased glioblastoma 1-year survival rate from 1% to 43%.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
There has been studies that have been done with supplemental melatonin in breast cancer patients, two small clinical trials I've seen. There's been other cancer studies as well, but they're given them really high doses of melatonin, and in conjunction with other traditional therapies like radiation, it increases, like, the one-year survival rate from 36% to, like, 65%, or something like that.